HYB Stock Overview
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
HYB passed our risk checks.
HOYA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥113.00 |
| 52 Week High | JP¥123.05 |
| 52 Week Low | JP¥87.36 |
| Beta | 0 |
| 1 Month Change | -3.67% |
| 3 Month Change | -2.46% |
| 1 Year Change | 18.65% |
| 3 Year Change | 17.17% |
| 5 Year Change | 85.25% |
| Change since IPO | 867.88% |
Recent News & Updates
Recent updates
Shareholder Returns
| HYB | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 5.8% | -0.6% | 1.8% |
| 1Y | 18.6% | -9.5% | 2.2% |
Price Volatility
| HYB volatility | |
|---|---|
| HYB Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 36,571 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
| HYB fundamental statistics | |
|---|---|
| Market cap | €39.41b |
| Earnings (TTM) | €1.00b |
| Revenue (TTM) | €4.57b |
39.3x
P/E Ratio8.6x
P/S RatioIs HYB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYB income statement (TTM) | |
|---|---|
| Revenue | JP¥758.80b |
| Cost of Revenue | JP¥320.97b |
| Gross Profit | JP¥437.83b |
| Other Expenses | JP¥270.99b |
| Earnings | JP¥166.84b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | 475.98 |
| Gross Margin | 57.70% |
| Net Profit Margin | 21.99% |
| Debt/Equity Ratio | 3.0% |
How did HYB perform over the long term?
See historical performance and comparison